TLB Share Price

Open 3.17 Change Price %
High 3.17 1 Day 0.00 0.00
Low 3.17 1 Week -0.08 -2.46
Close 3.17 1 Month -1.13 -26.28
Volume 300 1 Year 2.18 220.20
52 Week High 7.43
52 Week Low 0.51
TLB Important Levels
Resistance 2 3.17
Resistance 1 3.17
Pivot 3.17
Support 1 3.17
Support 2 3.17
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TD 66.68 1.60%
TD 66.68 1.60%
SMF 3.32 -15.74%
SMF 3.32 -15.74%
TBE 0.03 0.00%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
NCU 0.64 14.29%
NCU 0.64 14.29%
CUM 0.90 13.92%
CUM 0.90 13.92%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
DNT 0.08 -20.00%
SMF 3.32 -15.74%
SMF 3.32 -15.74%
AVP 0.07 -12.50%
AVP 0.07 -12.50%
AVP 0.07 -12.50%
AVP 0.07 -12.50%
RDL 1.70 -11.46%
NKO 0.08 -11.11%
More..

TearLab Corp (TSE: TLB)

TLB Technical Analysis 3
As on 21st Apr 2017 TLB Share Price closed @ 3.17 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.57 & Buy for SHORT-TERM with Stoploss of 3.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
TLB Target for April
1st Target up-side 5.4
2nd Target up-side 6.52
3rd Target up-side 7.65
1st Target down-side 2.18
2nd Target down-side 1.06
3rd Target down-side -0.07
TLB Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.tearlab.com
TLB Address
TLB
7360 Carroll Road
Suite 200
San Diego, CA 92121
United States
TLB Latest News
TearLab Corp (TEAR) Getting Somewhat Positive Media Coverage, Analysis Finds   Transcript Daily   - 24th Apr 17
Insider Trading Activity TearLab Corp (NASDAQ:TEAR) – Major Shareholder Sold ...   Market Exclusive   - 01st Apr 17
TearLab Corp (TEAR) Releases Earnings Results, Beats Estimates By $0.09 EPS   The Cerbat Gem   - 29th Mar 17
TearLab Corporation Reports Fourth Quarter and Year End 2016 Financial Results   GlobeNewswire (press release)   - 10th Mar 17
TearLab Corporation to Report Fourth Quarter and Full-year 2016 Financial ...   GlobeNewswire (press release)   - 22nd Feb 17
TearLab Corporation Reports Third Quarter and September Year-To-Date 2016 ...   GlobeNewswire (press release)   - 07th Nov 16
TearLab Corporation Comments on Shire plc FDA Approval of Xiidra ...   GlobeNewswire (press release)   - 13th Jul 16
Why This Analyst Sees TearLab Shares Tripling   Benzinga   - 12th Jul 16
TearLab Announces Appointment of Wes Brazell as CFO   GlobeNewswire (press release)   - 07th Jul 15
2.38   MarketWatch   - 22nd Dec 09
Interactive Technical Analysis Chart TearLab Corp ( TLB TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on TearLab Corp
TLB Business Profile
TearLab Corp. operates as an ophthalmic device company in the United States. It is involved in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company’s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corp. was founded in 1996 and is headquartered in San Diego, California.